National Health Investors reports Q1 2026 results today with options positioning firmly skewed toward calls — an unusual posture for a healthcare REIT heading into earnings.
The options market is sending a distinctly bullish signal. The put/call ratio collapsed to 0.54 on Monday, nearly three standard deviations below its 20-day average of 0.88 — the most call-heavy reading in recent months. That shift stands out against the prior three weeks, where the PCR had been running steadily near 0.94, suggesting the move into calls is fresh and deliberate rather than a gradual drift. The stock has pulled back 9% over the past month to $75.71, down a further 1.9% on the week, so the call-side skew reads less like complacency and more like conviction that the selloff has been overdone.
Short positioning adds little pressure to the story. Short interest has edged up about 12% over the past month to 3.5% of the float — meaningful but not extreme. Borrowing costs have collapsed, falling from roughly 0.49% to just 0.06% over the same period, suggesting the incremental shorting has been easy and cheap rather than urgent. Borrow availability remains ample, well clear of any squeeze conditions.
The fundamental debate centres on two moving parts. Bulls point to a projected normalized FFO-per-share growth rate of nearly 8% annually over five years, pipeline optionality in skilled nursing lease resets, and a dividend score ranking in the 86th percentile — strong for income-oriented REIT holders. Bears flag a downward revision to the 2026 FFO estimate (now $5.00 per share, below consensus), uncertainty around rent resets from NHC, and lingering questions about operator financial health. On the analyst side, the most recent action — Wells Fargo trimming its target to $84 and Truist cutting to $89 while both held their ratings — points to a Street that remains broadly constructive but is recalibrating on near-term execution. The mean target of $89 implies roughly 18% upside from current levels, a gap that has widened materially as the stock has drifted lower. That spread, combined with the 93rd-percentile ranking on forward EPS growth momentum, gives bulls a concrete valuation anchor. Peers have fared better on the week — gained 3.9%, added 5.3%, and rose 3.2% — making NHI's relative underperformance a live question heading into the print.
The Q1 report is therefore less a referendum on whether NHI can grow and more a test of whether management can demonstrate that the NHC rent reset and SHOP operating trends are tracking ahead of the lowered bar the Street has already set.
See the live data behind this article on ORTEX.
Open NHI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
